Skip to main content
Premium Trial:

Request an Annual Quote

Genome Therapeutics Promotes Kley to VP For Functional Genomics

Premium

WALTHAM, Mass.--Genome Therapeutics announced the promotion of Nikolai Kley to vice-president, functional genomics. Kley joined Genome Therapeutics in January 1997 from Bristol-Myers Squibb Pharmaceutical Research Institute. At Genome Therapeutics, Kley and his team have strengthened the firm's functional genomics capabilities, notably in signal pathway analysis, protein interaction networks in yeast and mammalian systems, expression cloning, and drug target validation, according to Robert Hennessey, the company's president. Kley will continue to oversee Genome Therapeutics' functional genomics programs, including exploration of signaling pathways for the p53 tumor suppressor gene to identify new pharmaceutical targets for cancer.

Filed under

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.